Aging, memory, and mild cognitive impairment

Ronald Carl Petersen, Glenn E. Smith, Stephen C. Waring, Robert J. Ivnik, Emre Kokmen, Eric G. Tangelos

Research output: Contribution to journalArticle

526 Citations (Scopus)

Abstract

In recent years, patients who are at high risk for developing Alzheimer's disease (AD) have become a focus of study. Several research groups have identified these patients, developed diagnostic criteria, and followed the patients longitudinally. These patients therefore constitute a clinical entity that is suitable for therapeutic interventions. In this article, we report our 5-year experience at the Mayo Clinic in characterizing a group of patients with mild cognitive impairment. These subjects were recruited from community-dwelling individuals who were receiving general medical care in the Department of Internal Medicine. They received the diagnosis of mild cognitive impairment if they met the following criteria: (a) complaint of defective memory, (b) normal activities of daily living, (c) normal general cognitive function, (d) abnormal memory function for age, and (e) absence of dementia. In following more than 75 of these patients, some of whom have been studied for as long as 5 years, it appears that approximately 10% to 15% of the subjects evolve to AD each year. We therefore evaluated the cognitive profiles of these patients at the time of their initial diagnosis in an attempt to predict who would remain stable and who would evolve to AD. Certain features of learning and memory performance indicated patients who were more likely to progress, but the strongest predictor was their apolipoprotein E status. The patients who possessed an ε4 allele were more likely to convert to AD at a more rapid rate then those who were not carriers. Our results and similar data from other study groups indicate that diagnostic criteria can be defined for patients who are likely to convert to AD; the natural history of these patients is becoming apparent, and variables that predict ultimate conversion can be defined. Consequently, patients with mild cognitive impairment constitute an important group for study, particularly from the aspect of therapeutic interventions.

Original languageEnglish (US)
Pages (from-to)65-69
Number of pages5
JournalInternational Psychogeriatrics
Volume9
Issue numberSUPPL. 1
StatePublished - 1997

Fingerprint

Alzheimer Disease
Cognitive Dysfunction
Independent Living
Apolipoproteins E
Activities of Daily Living
Internal Medicine
Natural History
Cognition
Dementia
Alleles
Learning
Therapeutics
Research

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Aging
  • Psychiatry and Mental health
  • Psychology(all)
  • Clinical Psychology

Cite this

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Kokmen, E., & Tangelos, E. G. (1997). Aging, memory, and mild cognitive impairment. International Psychogeriatrics, 9(SUPPL. 1), 65-69.

Aging, memory, and mild cognitive impairment. / Petersen, Ronald Carl; Smith, Glenn E.; Waring, Stephen C.; Ivnik, Robert J.; Kokmen, Emre; Tangelos, Eric G.

In: International Psychogeriatrics, Vol. 9, No. SUPPL. 1, 1997, p. 65-69.

Research output: Contribution to journalArticle

Petersen, RC, Smith, GE, Waring, SC, Ivnik, RJ, Kokmen, E & Tangelos, EG 1997, 'Aging, memory, and mild cognitive impairment', International Psychogeriatrics, vol. 9, no. SUPPL. 1, pp. 65-69.
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Kokmen E, Tangelos EG. Aging, memory, and mild cognitive impairment. International Psychogeriatrics. 1997;9(SUPPL. 1):65-69.
Petersen, Ronald Carl ; Smith, Glenn E. ; Waring, Stephen C. ; Ivnik, Robert J. ; Kokmen, Emre ; Tangelos, Eric G. / Aging, memory, and mild cognitive impairment. In: International Psychogeriatrics. 1997 ; Vol. 9, No. SUPPL. 1. pp. 65-69.
@article{91b50ec876d945ab92cc8106ffecff2c,
title = "Aging, memory, and mild cognitive impairment",
abstract = "In recent years, patients who are at high risk for developing Alzheimer's disease (AD) have become a focus of study. Several research groups have identified these patients, developed diagnostic criteria, and followed the patients longitudinally. These patients therefore constitute a clinical entity that is suitable for therapeutic interventions. In this article, we report our 5-year experience at the Mayo Clinic in characterizing a group of patients with mild cognitive impairment. These subjects were recruited from community-dwelling individuals who were receiving general medical care in the Department of Internal Medicine. They received the diagnosis of mild cognitive impairment if they met the following criteria: (a) complaint of defective memory, (b) normal activities of daily living, (c) normal general cognitive function, (d) abnormal memory function for age, and (e) absence of dementia. In following more than 75 of these patients, some of whom have been studied for as long as 5 years, it appears that approximately 10{\%} to 15{\%} of the subjects evolve to AD each year. We therefore evaluated the cognitive profiles of these patients at the time of their initial diagnosis in an attempt to predict who would remain stable and who would evolve to AD. Certain features of learning and memory performance indicated patients who were more likely to progress, but the strongest predictor was their apolipoprotein E status. The patients who possessed an ε4 allele were more likely to convert to AD at a more rapid rate then those who were not carriers. Our results and similar data from other study groups indicate that diagnostic criteria can be defined for patients who are likely to convert to AD; the natural history of these patients is becoming apparent, and variables that predict ultimate conversion can be defined. Consequently, patients with mild cognitive impairment constitute an important group for study, particularly from the aspect of therapeutic interventions.",
author = "Petersen, {Ronald Carl} and Smith, {Glenn E.} and Waring, {Stephen C.} and Ivnik, {Robert J.} and Emre Kokmen and Tangelos, {Eric G.}",
year = "1997",
language = "English (US)",
volume = "9",
pages = "65--69",
journal = "International psychogeriatrics / IPA",
issn = "1041-6102",
publisher = "Cambridge University Press",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Aging, memory, and mild cognitive impairment

AU - Petersen, Ronald Carl

AU - Smith, Glenn E.

AU - Waring, Stephen C.

AU - Ivnik, Robert J.

AU - Kokmen, Emre

AU - Tangelos, Eric G.

PY - 1997

Y1 - 1997

N2 - In recent years, patients who are at high risk for developing Alzheimer's disease (AD) have become a focus of study. Several research groups have identified these patients, developed diagnostic criteria, and followed the patients longitudinally. These patients therefore constitute a clinical entity that is suitable for therapeutic interventions. In this article, we report our 5-year experience at the Mayo Clinic in characterizing a group of patients with mild cognitive impairment. These subjects were recruited from community-dwelling individuals who were receiving general medical care in the Department of Internal Medicine. They received the diagnosis of mild cognitive impairment if they met the following criteria: (a) complaint of defective memory, (b) normal activities of daily living, (c) normal general cognitive function, (d) abnormal memory function for age, and (e) absence of dementia. In following more than 75 of these patients, some of whom have been studied for as long as 5 years, it appears that approximately 10% to 15% of the subjects evolve to AD each year. We therefore evaluated the cognitive profiles of these patients at the time of their initial diagnosis in an attempt to predict who would remain stable and who would evolve to AD. Certain features of learning and memory performance indicated patients who were more likely to progress, but the strongest predictor was their apolipoprotein E status. The patients who possessed an ε4 allele were more likely to convert to AD at a more rapid rate then those who were not carriers. Our results and similar data from other study groups indicate that diagnostic criteria can be defined for patients who are likely to convert to AD; the natural history of these patients is becoming apparent, and variables that predict ultimate conversion can be defined. Consequently, patients with mild cognitive impairment constitute an important group for study, particularly from the aspect of therapeutic interventions.

AB - In recent years, patients who are at high risk for developing Alzheimer's disease (AD) have become a focus of study. Several research groups have identified these patients, developed diagnostic criteria, and followed the patients longitudinally. These patients therefore constitute a clinical entity that is suitable for therapeutic interventions. In this article, we report our 5-year experience at the Mayo Clinic in characterizing a group of patients with mild cognitive impairment. These subjects were recruited from community-dwelling individuals who were receiving general medical care in the Department of Internal Medicine. They received the diagnosis of mild cognitive impairment if they met the following criteria: (a) complaint of defective memory, (b) normal activities of daily living, (c) normal general cognitive function, (d) abnormal memory function for age, and (e) absence of dementia. In following more than 75 of these patients, some of whom have been studied for as long as 5 years, it appears that approximately 10% to 15% of the subjects evolve to AD each year. We therefore evaluated the cognitive profiles of these patients at the time of their initial diagnosis in an attempt to predict who would remain stable and who would evolve to AD. Certain features of learning and memory performance indicated patients who were more likely to progress, but the strongest predictor was their apolipoprotein E status. The patients who possessed an ε4 allele were more likely to convert to AD at a more rapid rate then those who were not carriers. Our results and similar data from other study groups indicate that diagnostic criteria can be defined for patients who are likely to convert to AD; the natural history of these patients is becoming apparent, and variables that predict ultimate conversion can be defined. Consequently, patients with mild cognitive impairment constitute an important group for study, particularly from the aspect of therapeutic interventions.

UR - http://www.scopus.com/inward/record.url?scp=0031440383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031440383&partnerID=8YFLogxK

M3 - Article

C2 - 9447429

AN - SCOPUS:0031440383

VL - 9

SP - 65

EP - 69

JO - International psychogeriatrics / IPA

JF - International psychogeriatrics / IPA

SN - 1041-6102

IS - SUPPL. 1

ER -